Trials / Completed
CompletedNCT00240110
Valproate Efficacy in Cocaine-Bipolar Comorbidity
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 152 (actual)
- Sponsor
- University of Miami · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This proposal will test the efficacy of a promising pharmacological approach for the treatment of comorbid cocaine dependence and bipolar disorder. We propose a randomized, double blind, placebo controlled 12-week trial to test the efficacy of Divalproex sodium (Valproate) plus treatment as usual compared to placebo plus treatment as usual in decreasing cocaine use and stabilizing mood symptoms among patients with comorbid cocaine dependence and bipolar disorder. Treatment as usual includes the use of lithium carbonate for mood stabilization plus supportive psychosocial treatment.
Detailed description
Bipolar disorder has the highest rate of association with cocaine and other substance use disorders than any other major severe psychiatric syndrome. This comorbidity represents a major treatment challenge and is associated with severe disability, morbidity, and heightened risk for suicide. The aims of this study are: 1. Examine the efficacy of valproate plus treatment as usual compared to placebo plus treatment as usual in decreasing cocaine use in patients with cocaine dependence and comorbid bipolar disorder. 2. Determine whether primary vs. secondary cocaine dependence, bipolar subtype (depressed vs. manic/mixed) and the presence of additional substance use disorders moderate the association between treatment and cocaine use outcome. 3. Assess the effects of medication compliance and mood symptoms as mediators of cocaine use outcome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Valproate | Valproate with dose titration to achieve blood levels within the therapeutic range |
| DRUG | Placebo | Control arm |
| DRUG | Lithium Carbonate | All participants were started and stabilized on lithium carbonate as a standard treatment for bipolar disorder |
Timeline
- Start date
- 2006-03-01
- Primary completion
- 2014-03-01
- Completion
- 2014-03-01
- First posted
- 2005-10-17
- Last updated
- 2016-10-17
- Results posted
- 2016-10-17
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00240110. Inclusion in this directory is not an endorsement.